Emergencias
-
To perform an in-depth analysis of the process of transferring patients from an emergency department (ED) to other areas inside a hospital and identify possible points of failure and risk so that strategies for improvement can be developed. ⋯ The FMEA method helped the group to identify points when there is risk of failure during patient transfers and to define ways to improve patient safety.
-
To analyze whether urinary catheterization in a hospital emergency department (ED) affects short-term prognosis in patients with acute heart failure (AHF). ⋯ Routine insertion of a urinary catheter in patients with AHF in the ED is associated with worse 30-day clinical outcomes.
-
The aims of this study in the Emergency Department and Elder Needs (EDEN) series were to explore associations between clinical variables on arrival at the ED (baseline) and the insertion of a bladder catheter, and the relation between catheterization and deterioration to a more complex or serious clinical state. ⋯ Certain patient characteristics and baseline clinical conditions are associated with bladder catheterization in patients of advanced age. The main factors were decreased consciousness, dehydration, and male sex. Even after adjustment for related factors, catheterization is independently associated with progression to more complex or serious clinical states.
-
To analyze factors related to the use of digoxin to treat patients with acute heart failure (AHF) in emergency departments (EDs) and the impact of digoxin treatment on short-term outcomes. ⋯ Digoxin continues to be used in one out of ten ED patients who are not already on long-term treatment with the drug. Digoxin use is associated with cardiac decompensation triggered by atrial fibrillation with rapid ventricular response, younger age, women, and patients with better initial NYHA function status but possibly more severe decompensation. Digoxin use leads to a longer ED stay but is safe, as it is not associated with need for admission, prolonged hospitalization, or short-term mortality.
-
In the article "Emergency department management of atrial fibrillation: 2023 consensus from the Spanish Society of Emergency Medicine (SEMES), the Spanish Society of Cardiology (SEC), and the Spanish Society of Thrombosis and Hemostasis (SETH)" published in Volume 35, Issue 5, October 2023, October 2023, there were some errors that are detailed and corrected below: On page 361, Figure 1, this originally published figure contained errors and would be replaced by the one attached below. On page 363, Table 1, in the column for rivaroxaban dose, where it says 20 mg/12 h, it should read 20 mg/24 h. On page 365, Figure 3, this originally published figure contained errors and would be replaced by the figure below.